Skip to main content
TipRanks
Go Ultimate75% OFF

Harvard Bioscience (HBIO) Revenue

278 Followers

Harvard Bioscience Revenue

Harvard Bioscience had a revenue of 22.20M in the quarter ending Sep 30, 2026, with -2.34%. This bring the company's revenue in the last twelve months to 89.41M, Increased 1.83%. In the fiscal year ending Dec 31, 2025, Harvard Bioscience had annual revenue of 86.55M with -8.06% growth.

Revenue (ttm)
89.41M
Revenue Growth
2.34%
P/S Ratio
0.50
Revenue/Employee
$263,872
Employees
328
Market Cap
$42.94M

Revenue Chart

Harvard Bioscience Revenue - Annual

025M50M75M100M125M150M101.88M120.77M116.18M102.10M118.90M113.33M112.25M94.14M86.55M201720182019202020212022202320242025
Revenue History
Download to Excel
HBIO revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202586.55M-7.58M-8.06%
Dec 31, 202494.14M-18.11M-16.14%
Dec 31, 2023112.25M-1.08M-0.96%
Dec 31, 2022113.33M-5.57M-4.68%
Dec 31, 2021118.90M16.80M16.46%
Dec 31, 2020102.10M-14.08M-12.12%
Dec 31, 2019116.18M-4.60M-3.81%
Dec 31, 2018120.77M18.89M18.54%
Dec 31, 2017101.88M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
HBIO89.41M
RVP33.90M
MLSS9.28M
NXGL12.31M